Wang Lai Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$4.1M

Insider Activity of Wang Lai

According to the SEC Form 4 filings, Wang Lai, being in a position of

  1. President, Global Head of R&D at BeOne Medicines AG,
    оver the last 12 months, has bought 0 shares, and sold 4360 shares for $1.17M,
    over all time since 2025-06-06, has bought 0 shares, and sold 17737 shares for $5.28M.

Biography of Wang Lai

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,171,3534100

Comparison of Insiders on Amount of Buys and Sells

2026-06-23SaleBeOne Medicines AG
ONC
President, Global Head of R&D
1,068
0.001%
$276.74$295,553+28.37%
2026-06-16SaleBeOne Medicines Ltd.
ONC
President, Global Head of R&D
1,169
0.0011%
$265.39$310,236+33.93%
2026-06-11SaleBeOne Medicines Ltd.
ONC
President, Global Head of R&D
756
0.0007%
$261.00$197,318+35.04%
2026-06-08SaleBeOne Medicines Ltd.
ONC
President, Global Head of R&D
1,367
0.0013%
$269.38$368,247+29.62%
2025-09-09SaleBeOne Medicines Ltd.
ONC
Global Head of R&D
5,000
0.0049%
$350.06$1.75M-9.27%
2025-07-30SaleBeOne Medicines Ltd.
ONC
Global Head of R&D
259
0.0002%
$305.00$78,995+4.58%
2025-07-29SaleBeOne Medicines Ltd.
ONC
Global Head of R&D
4,041
0.0034%
$302.49$1.22M+2.55%
2025-06-23SaleBeOne Medicines Ltd.
ONC
Global Head of R&D
1,028
0.0007%
$260.00$267,280+21.28%
2025-06-17SaleBeOne Medicines Ltd.
ONC
Global Head of R&D
470
0.0003%
$251.37$118,142+22.91%
2025-06-16SaleBeOne Medicines Ltd.
ONC
Global Head of R&D
1,177
0.0009%
$266.40$313,558+18.11%
2025-06-06SaleBeOne Medicines Ltd.
ONC
Global Head of R&D
1,402
0.001%
$252.39$353,853+22.06%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.